1-2 of 2
Authors: Scott Vuocolo
Sort by
Journal Article
From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials
Jonathan M Meyer and others
International Journal of Neuropsychopharmacology, Volume 28, Issue 4, April 2025, pyaf015, https://doi.org/10.1093/ijnp/pyaf015
Published: 08 March 2025
Journal Article
EFFICACY OF KARXT ON NEGATIVE SYMPTOMS IN ACUTE SCHIZOPHRENIA: AN ANALYSIS OF POOLED DATA FROM 3 TRIALS
*Scott Vuocolo and others
International Journal of Neuropsychopharmacology, Volume 28, Issue Supplement_1, February 2025, Pages i358–i359, https://doi.org/10.1093/ijnp/pyae059.636
Published: 12 February 2025
Advertisement
Advertisement